Hepatitis A and B seropositivity among medical students

Öncü, Serkan; Öncü, Selcen; Sakarya, Serhan

doi:10.1016/j.healthpol.2004.12.004

Cited by 17 publications

(10 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A large number of studies have been reported mainly from Turkey and Iran. The overall prevalence rate reported in different provinces of Turkey during the past 10 years among young adults (≤19 years old) ranges between 13% and 64% . An increasing trend was observed till 2008 (29% up to 63.8%) followed by a sharp decline observed in 2010 and 2012 (13% and 29.5%, respectively).…”

Section: Resultsmentioning

confidence: 98%

Hepatitis A virus in the Middle East and North Africa region: a new challenge

Melhem

Talhouk

Rachidi

et al. 2014

Journal of Viral Hepatitis

View full text Add to dashboard Cite

During the past three decades, a gradual shift in the age of infection with hepatitis A virus (HAV) from early childhood to adulthood has been observed. There is a general lack of updated data on HAV burden of disease, incidence and age-specific seroprevalence in countries of the Middle East and North Africa (MENA) region. The aim of this article is to review the published data on anti-HAV seroprevalence, an important tool to monitor infections rates, in countries of the MENA region and associated risk factors including water and socioeconomic data when available. Data on anti-HAV seroprevalence were found for 12 of 25 MENA countries. We show that MENA countries, similar to other areas in the world, have a clear shift in HAV incidence with a decline among young age groups and an increase among adults and older individuals. This would likely be associated with increased morbidity and increased risks of outbreaks among younger age groups. Consequently, the continuous surveillance of hepatitis A cases and the inclusion of hepatitis A vaccine in the expanded immunization programmes are needed in countries of the MENA.

show abstract

Section: Resultsmentioning

confidence: 98%

Hepatitis A virus in the Middle East and North Africa region: a new challenge

Melhem

Talhouk

Rachidi

et al. 2014

Journal of Viral Hepatitis

View full text Add to dashboard Cite

show abstract

“…We compared the prevalence rates of studies between 1990 and 1999, and 2000 and 2009 for both health care workers (HCW) [62-83] and health care students (HCS) [84-87]. Table 4 shows the decrease in prevalence within the 10-year periods before and after vaccination for HCW and HCS; the WMP decreased from 3.34 to 2.29, and from 3.31 to 2.08, respectively.…”

Section: Resultsmentioning

confidence: 99%

Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

et al. 2011

View full text Add to dashboard Cite

BackgroundTo provide a clear picture of the current hepatitis B situation, the authors performed a systematic review to estimate the age- and region-specific prevalence of chronic hepatitis B (CHB) in Turkey.MethodsA total of 339 studies with original data on the prevalence of hepatitis B surface antigen (HBsAg) in Turkey and published between 1999 and 2009 were identified through a search of electronic databases, by reviewing citations, and by writing to authors. After a critical assessment, the authors included 129 studies, divided into categories: 'age-specific'; 'region-specific'; and 'specific population group'. To account for the differences among the studies, a generalized linear mixed model was used to estimate the overall prevalence across all age groups and regions. For specific population groups, the authors calculated the weighted mean prevalence.ResultsThe estimated overall population prevalence was 4.57, 95% confidence interval (CI): 3.58, 5.76, and the estimated total number of CHB cases was about 3.3 million. The outcomes of the age-specific groups varied from 2.84, (95% CI: 2.60, 3.10) for the 0-14-yearolds to 6.36 (95% CI: 5.83, 6.90) in the 25-34-year-old group.ConclusionThere are large age-group and regional differences in CHB prevalence in Turkey, where CHB remains a serious health problem.

show abstract

“…Although hepatitis A virus (HAV) infection is a self-limited disease, the infection in adults causes significant morbidity, resulting in long absences from work for several weeks, possible hospitalization, and occasional mortality resulting from acute fulminant hepatitis (1, 2). Infection rates have declined with better hygiene practice and public sanitation, but remain heterogeneous across geographic and socioeconomic strata (1, 2). …”

Section: Introductionmentioning

confidence: 99%

Incidence and Seroprevalence of Hepatitis A Virus Infections among Young Korean Soldiers

et al. 2007

View full text Add to dashboard Cite

This study was performed to determine the incidence and seroprevalence of hepatitis A virus (HAV) infections in young soldiers in the Republic of Korea Army. From January 2000 through December 2004, a total of 147 hepatitis A cases were reported to the Armed Forces Medical Command. The annual incidence rates were 7.4 per 100,000 persons in 2000, 1.6 in 2001, 4.4 in 2002, 9.8 in 2003, and 6.2 in 2004, based on the reported cases among approximately 500,000 soldiers. All patients were males with a median age of 21 yr (range, 19-27). The most common symptom was nausea (86.5%), and all patients had recovered without complications. In addition, in order to evaluate the seroprevalence of HAV infection in young adults, serum samples were obtained from randomly selected young subjects among those who had been admitted to the Armed Forces Capital Hospital from September 2005 to February 2006. A total of 200 subjects were enrolled in the study to analyze the anti-HAV immune status. The overall anti-HAV IgG seropositive rate was 2% (4/200, 95% CI, 0.60-5.21%). Given the changing epidemiology of the disease and the associated increase in morbidity, it was suggested that the routine HAV vaccination for Korean military personnel might be necessary.

show abstract

Hepatitis A and B seropositivity among medical students

Cited by 17 publications

References 26 publications

Hepatitis A virus in the Middle East and North Africa region: a new challenge

Hepatitis A virus in the Middle East and North Africa region: a new challenge

Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

Incidence and Seroprevalence of Hepatitis A Virus Infections among Young Korean Soldiers

Contact Info

Product

Resources

About